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Abstract
Background: We aimed to determine whether family practices’ achievement of diabetes quality of care targets is associated
with diabetic retinal disease in registered patients.
Methods: Data for achievement of diabetes quality of care targets, including the proportion of patients with HbA1c#7.5%,
for 144 family practices in London UK, for the years 2004/5 to 2007/8, were linked to data from a population-based diabetes
eye screening programme collected from September 2007 to February 2009. Analyses were adjusted for age, sex, duration
and type of diabetes, unadjusted diabetes prevalence, ethnicity and deprivation category.
Results: Data were analysed for 24,458 participants with one or more eye screening results in the period. There were 9,332
(38%) with any diabetic retinopathy and 2,819 (11.5%) with sight threatening diabetic retinopathy (STDR), including 2,654
(10.9%) with maculopathy. Among participants registered at 13 family practices that were in the highest quartile for
achievement of the HbA1c quality of care target for all four years of study, the relative odds of any diabetic retinopathy
were 0.78 (0.69 to 0.88) P,0.001. For participants at 12 practices consistently in the lowest quartile of HbA1c achievement,
the relative odds of any diabetic retinopathy were 1.16 (1.03 to 1.30), P = 0.015. In the highest achieving practices, the
relative odds of maculopathy were 0.74 (0.62 to 0.89), P = 0.001 and STDR 0.77 (0.65 to 0.92), P = 0.004.
Conclusions: The risk of diabetic retinopathy might be lower at family practices that consistently achieve highly on diabetes
quality of care targets for HbA1c.
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Introduction
Maintaining and enhancing the quality of medical care is an
increasing concern for all health systems. The US Institute of
Medicine [1] drew attention to the ‘quality chasm’ that exists
between the potential of modern medical management of chronic
illnesses and the reality of routine chronic illness care. As a result,
patients experience a considerable burden of preventable compli-
cations, and funders and providers of health services face rapidly
escalating costs of chronic illness care.[2]
The use of incentives to encourage professionals to adhere to
specific processes of care and achieve designated quality of care
targets for intermediate outcome measures has received growing
attention as one strategy to improve the quality of chronic illness
care.[3] The English National Health Service has made systematic
use of contractual financial incentives through a program for family
practitioners known as the Quality and Outcomes Framework
(QOF).[4] The program was introduced in 2004 to reward family
practices for achieving clinical targets across a range of chronic
conditions, including diabetes. Up to one-third of practice income
may be derived from pay-for-performance incentives, with diabetes
accounting for nearly 10% of all incentives. Several studies have
demonstrated improving clinical performance under these new
contractual arrangements, including increased levels of achieve-
ment of key process measures and intermediate outcomes.[5–8]
Inequalities in care have also diminished.[9]
However, there remain significant doubts concerning the value
of an approach based on quality of care targets. The system is
costly and may emphasise only the more tangible aspects of patient
care.[10] The apparent benefits may reflect improved recording of
clinical information and it is not yet clear that these are translated
into better patient outcomes. A key question concerns whether
family practices’ achievement of quality of care targets is
associated with better health outcomes. In the present study, we
aimed to determine whether family practices’ consistent high-
achievement of the HbA1c target was associated with the
subsequent risk of diabetic eye disease. We linked data on
practices achievement of pay-for-performance targets in the period
2004 to 2008, to the results of a population-based diabetes eye
screening programme obtained in the period 2007 to 2009.
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Methods
The study was set in three inner-city boroughs in London UK
that are characterised by high levels of social and material
deprivation and have about one third of their total population
drawn from black and ethnic minority groups. Family practices
were included in the study if they were located in the three
boroughs and contributed data to the Quality and Outcome
Framework in all four years of study. Data for the achievement of
QOF targets for diabetes were obtained from the NHS
Information Centre as reported previously.[11] Data were
analysed for the family practice-specific proportions of eligible
diabetic patients in each year whose HbA1c was #7.5%, blood
pressure was #145/85 mmHg or serum cholesterol was
#5 mmol/l.[8] For each year of study, we grouped family
practices into quartiles for achievement of each target. We then
identified family practices that remained in the top quartile for
achievement of HbA1c targets throughout all four years of study.
We also identified those practices that remained in the bottom
quartile of achievement of the HbA1c target throughout all four
years of study. Similarly, we identified those practices that always
remained in the top quartile for achievement of blood pressure or
cholesterol targets. Data were also included for the prevalence of
diabetes at each practice in 2007, based on the number of diabetes
subjects included in the practice diabetes register and the practice
list size. However, it was not possible to adjust diabetes prevalence
for the varying distributions of age or ethnicity at different
practices. Family practice level data for the achievement of targets
were then linked to data for population-based diabetes eye
screening using the National Health Service (NHS) general
practice code. This code is unique to each family practice. The
NHS general practice code was never missing from the Quality
and Outcomes Framework data; neither was the NHS general
practice code ever missing from any of the screening records. This
is because the screening programme draws participants from
general practice registers as the sampling frame.
The English diabetic retinopathy screening program is offered
annually to all patients with diabetes who are registered with
family practices in England.[12] In the three London boroughs
included in this report, all diabetic patients registered with
practices are offered appointments. Patients may also be referred
by family practices or diabetes specialists. Screening is by 2-field
digital photography. Photographs are primary and second-disease
graded as recommended by the English National Screening
Programme for Diabetic Retinopathy.[13] If there is a difference
of classification, the images are referred for arbitration grade by
consultant ophthalmologists. Screening outcomes were analysed
using grades recorded separately for each eye. Participants were
classified as not attending for screening if they were called for
screening but had no recorded eye grade during the study period.
Participants were classified as having maculopathy if the eye grade
was recorded as M1 in either eye. Participants were recorded as
having any diabetic retinopathy if the eye grading was recorded as
R1, R2 or R3 in either eye. Sight-threatening diabetic retinopathy
(STDR) is defined as any grade that includes severe non-
proliferative retinopathy (R2), proliferative retinopathy (R3),
and/or maculopathy (M1). Data for screening outcomes were
analysed using the highest grades of eye disease recorded during
the period.
Other fields included in analyses included age by ten year age
group; sex; type of diabetes including Type 1, Type 2 and ‘Other
and not specified’; duration of diabetes by five year group and a
category for not known. The postcode of the subject’s home
address was linked to the Super Output Area (SOA) Indices of
Multiple Deprivation 2007 (IMD) Score.[14] SOAs are small
geographical units with resident populations of approximately
1,500 participants. The sample was divided into quintiles of
deprivation using the ranks of the IMD scores. Self-assigned
ethnicity recorded at the time of screening was analysed using the
categories ‘African’, ‘Caribbean’, ‘Black other’, ‘South Asian’,
‘Mixed’, ‘Other ethnic group’ and ‘not known’.
Data were tabulated and random effects logistic regression
models were fitted using Stata version 11.[15] Data were analysed
at the individual participant level. Family practice was included as
a random effect. In order to evaluate the stability of the estimates
obtained we performed several sensitivity analyses. We allowed for
the exclusion by practices of a small proportion of diabetic
participants as ‘exceptions’. We corrected the estimated achieve-
ment of the HbA1c target for exceptions by multiplying the
percent achievement by 100 minus the percent excluded as
exceptions at each practice. Analyses were repeated using the
exception-corrected values. We also repeated the analyses using
the practices included in the highest or lowest tertiles rather than
quartiles. We also repeated the analyses using estimation by
Generalised Estimating Equations. The results of these sensitivity
analyses are presented.
The Research Ethics Committee of Guy’s Hospital, London
reviewed the proposal for this project and advised that the project
was a service evaluation and was not required to be ethically
reviewed under the terms of the Governance Arrangements for
Research Ethics Committees in the UK (Reference 2008–11; letter
dated 29th July 2008). Data analysed for the project were derived
from the minimum data set for the diabetic retinopathy screening
programme. The proposal to access fully anonymised records was
approved by the Caldicott Guardian of Guy’s and St Thomas’
Hospital (communication dated 18th June 2008).
Results
Figure 1 shows flowcharts detailing the inclusion and exclusion
of family practices and screening records for the study. There were
152 family practices in the three boroughs during the period 2004
to 2008 but seven practices did not contribute data on pay-for-
performance targets in each year of study and were excluded, as
was one practice that had no participants included in the diabetes
eye screening database, leaving 144 practices (95%) for further
analysis. The 144 study practices identified 31,458 registered
diabetic participants in their 2007–8 QOF returns. The median
number of diabetic patients per practice was 178 (interquartile
range 131 to 280). There were 36 practices in the highest quartile
for HbA1c target in 2004–5 of whom 21 were also in the highest
quartile in 2005–6, 17 in 2006–7 and 22 in 2007–8. There were 13
practices that remained in the top quartile for achievement of the
HbA1c target throughout the period 2004 to 2008. There were 12
practices that remained in the bottom quartile for achievement of
HbA1c target throughout this period.
Data were obtained from the Diabetes Eye Screening Program
for all episodes from 1st September 2007 to 28th February 2009.
Initially, data were evaluated for 76,351 records but 4,567
duplicate episodes were excluded; as were 4,138 episodes excluded
as ineligible for screening because they attended a different
hospital for eye screening (252), were deceased (2,630), were
medically unfit (86), moved out of the area (925), were blind (27),
denied being diabetic (65) , were under 12 years of age (10) or had
opted out of the screening programme (143); 6,750 episodes with
appointment dates after 28th February 2008; 319 records excluded
for participants that were not resident in South London boroughs,
1,003 from non-study practices; and 79 records with missing
HbA1c and Diabetic Retinopathy
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gender. There were then 59,495 records of appointments and
episodes, from 31,484 participants, available for further analysis of
whom 24,458 took up the screening offer and had retinal
photographs performed.
Table 1 shows the characteristics of practices and individual
patients included in the study groups. For practices that were
always in the highest quartile for HbA1c achievement, the family
practice-specific median (interquartile range) percent of patients
achieving HbA1c#7.5% was 66.7 (62.4 to 70.7) in 2004–5
increasing to 74.5 (72.7 to 80.6) in 2007–8. For practices that were
always in the lowest quartile, the equivalent figures were 40.7 (38.4
to 43.9) in 2004–5 increasing to 52.5 (48.9 to 55.7) in 2007–8. In
2007, median achievement of the blood pressure target for the
higher group of practices was 87% compared with 68% for the
lower group of practices; for the cholesterol target the median
achievement was 87% and 71% for higher and lower performing
practices respectively. Higher achieving practices were generally
similar to all practices but they showed a slightly higher rate of
exception reporting than all practices. Practices that were low
achieving for the Hba1c target showed lower screening uptake, a
higher proportion of ethnic minority patients and a higher
proportion of registered diabetic patients resident in the most
deprived areas. Individual patient deprivation score ranks were
correlated within practices, with an intraclass correlation coeffi-
cient of 0.28.
Table 2 shows the distribution of any diabetic retinopathy,
maculopathy and sight threatening diabetic retinopathy for
practices in relation to achievement of pay-for-performance
targets over time. Odds ratios were adjusted for age group, sex,
type of diabetes, duration of diabetes, self-reported ethnic group
and deprivation quintile as well as each of the variables shown. For
practices that always remained in the highest quartile for HbA1c
achievement, the prevalence of any diabetic retinopathy was
approximately 4% lower, with maculopathy 2% lower and STDR
2% lower, than for other practices. In adjusted analyses, the
relative odds of diabetic retinopathy were approximately 22%
lower for high achieving practices than for other practices. The
estimated adjusted relative odds for maculopathy and STDR were
also lower for practices that achieved highly on HbA1c targets
than other practices. For practices that were always in the lowest
quartile for HbA1c achievement the prevalence of any diabetic
retinopathy was approximately 3% higher, and the adjusted
relative odds of any diabetic retinopathy were about 16% higher
than for other practices. Similar point estimates were observed for
maculopathy or STDR, but associations for these outcomes did
not reach conventional levels of statistical significance. There was
no association of diabetic retinopathy with consistently high
achievement of the blood pressure target or the cholesterol target.
In a one-way analysis of variance, there was evidence of
practice-level variation in the distribution of retinopathy. Intra-
class correlation coefficients (ICCs) by practice were: for diabetic
retinopathy 0.007 (P,0.001), for maculopathy 0.003 (P,0.001)
and for sight-threatening retinopathy 0.001 (P= 0.003). These
small ICCs may be interpreted as showing evidence of practice-
Figure 1. Flowcharts showing selection of family practices and screening records for analysis. Figure 1a): Selection of family practices.
Figure 1b): Selection of records for analysis.
doi:10.1371/journal.pone.0010424.g001
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level variation in the three measures of retinal disease. The ICCs
were of small magnitude suggesting that within practices the
distribution of retinal disease is, as expected, largely determined by
individual characteristics such as the duration of diabetes and
quality of blood glucose control in each subject.
Table 3 shows the results of sensitivity analyses. Correction for
practices’ exclusion of certain patients as exceptions tended to
increase the strength of estimated associations. Use of tertiles,
rather than quartiles, for analysis tended to diminish observed
associations but did not eliminate them. There were 20 family
practices (14%) always in the top tertile, and 17 (12%) of practices
always in the bottom tertile, for HbA1c achievement. Use of
alternative statistical methods for estimation did not alter
conclusions. No association with any diabetic retinopathy was
observed for family practices that were in the highest or lowest
quartiles for only two or three years of study.
Discussion
These results suggest that diabetic patients who are registered
with family practices that consistently achieve highly on targets for
HbA1c have a reduced risk of retinopathy. This association is
biologically plausible. In type 2 diabetes, a 1% reduction in mean
HbA1c in type 2 diabetes is associated with a 37% reduction in
risk of microvascular complications.[16] In type 1 diabetes,
differences in HbA1c explain ‘virtually all’ of the risk of
microvascular complications of diabetes.[17] Although the asso-
ciation between HbA1c and retinopathy is well established [18],
few studies have identified organisational characteristics that may
mediate this relationship. The association between HbA1c
achievement and retinopathy was graded, with practices that are
consistently in the lowest quartile for achievement of the HbA1c
target showing an increased risk of retinopathy. We did not find a
large effect. However, four years is a short space of time in the
evolution of diabetic retinopathy and the detection of
any association may be clinically important. The study had
the strength of the large sample size required to detect small
effects.
The association between HbA1c achievement and retinopathy
was specific. Associations were not observed for achievement of
blood pressure or cholesterol targets. Lower blood pressure is
associated with a reduced rate of progression of diabetic
retinopathy. In the UK Prospective Diabetes Study, tight blood
pressure control was associated with a 34% reduction in
retinopathy progression over nine years.[19] High achievement
of blood pressure targets might be expected to be associated with
reduced retinopathy but this was not observed in these analyses.
One possible explanation may be the generally high level of
achievement of blood pressure targets in the Quality and
Outcomes Framework. In England, the blood pressure target
was achieved for median 71% of diabetic patients in 2004–5 and
80% in 2007–8.[8] In our data, the top performing practices had
87% achievement of the blood pressure target in 2007, compared
with 77% for all other practices and 68% for the lowest
Table 1. Characteristics of participants according to pay-for-performance category.
Achievement of HbA1c target
All practices
Practices always
in top quartile
2004–2008 P valuea
Practices always
in bottom quartile
2004–2008 P valuea
Practice-level data
Practices 144 13 12
Diabetes patients per practice (median, IQR)b 178 (131 to 278) 190 (157 to 233) 0.300 166 (109 to 302) 0.969
Diabetes prevalence (median, IQR, %) 3.4 (2.9 to 4.1) 3.0 (2.4 to 3.7) 0.116 3.7 (3.1 to 4.6) 0.198
Percent excepted from HbA1c target in 2007
(median, IQR)b
10.8 (7.6 to 14.4) 12.1 (7.7 to 19.5) 0.021 9.8 (6.7 to 15.6) 0.945
Percent of registered patients achieving
HbA1c#7.5% (median, IQR)b
2004 53.3 (46.5 to 59.4) 66.7 (62.4 to 70.7) 40.7 (38.4 to 43.9)
2005 56.8 (50.0 to 63.3) 79.4 (72.0 to 80.8) 46.5 (40.4 to 48.4)
2006 63.2 (55.9 to 70.0) 74.4 (72.3 to 83.9) 50.9 (46.9 to 53.1)
2007 63.6 (58.5 to 68.2) 74.5 (72.7 to 80.6) 52.5 (48.9 to 55.7)
Patient-level data
Called for screening 31,484 2,440 2,668
Screened 24,458 (78) 1,955 (80) 0.046 1,948 (73) 0.001
Femalec 11,966 (49) 952 (49) 0.859 964 (49) 0.576
Type 1c 1,571 (6) 144 (7) 0.254 106 (5) 0.174
Diabetes duration $10 yearsc 8,078 (26) 668 (27) 0.140 646 (24) 0.574
Ethnic minority groupc 10,353 (42) 809 (41) 0.814 1,140 (59) 0.001
Most deprived quintilec 4,863 (20) 334 (17) 0.442 561 (29) 0.029
Least deprived quintilec 4,952 (20) 497 (25) - 212 (11) -
Figures are frequencies (percent) except where indicated.
atest for difference between category and practices or patients not in that category.
bfigures are median (IQR) for distribution of practice-specific proportions.
cfigures are frequencies and percent of those who were screened for diabetic eye disease.
doi:10.1371/journal.pone.0010424.t001
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performing practices. These figures indicate a higher overall
achievement, and slightly smaller disparities, for the blood pressure
target as compared to the HbA1c target.
We evaluated the achievement of quality of care targets during a
four-year period before the evaluation of diabetic retinopathy.
Nevertheless, we cannot determine whether the observed
differences in the frequency of retinopathy were not already
present before the introduction of pay-for-performance. In
common with other studies that have evaluated the English pay-
for-performance program [5,9], our study did not have the
benefits of a control group and allocation through randomisation.
It is therefore important to employ appropriate caution in drawing
possible causal inferences. We cannot prove that the pay-for-
performance incentives were the cause of lower HbA1c values at
study practices and the findings may not be applicable outside the
context of UK primary care. Nevertheless, the results suggest an
important overall conclusion; family practices that on aggregate
achieve better blood glucose control, whatever its cause, may
experience less diabetic retinopathy in their patients.
Studies have shown that quality of primary care is associated
with socio-economic position [20] but in the UK inequalities in
diabetes care are becoming less consistent [21,22]. Residual
confounding might be advanced as an explanation for the
observed association between pay-for-performance achievement
and diabetic retinopathy. High-achieving practices served slightly
less deprived populations, and low-achieving practices served
substantially more deprived populations on average than other
practices. Low socio-economic position and deprivation have
generally been shown to be associated with increased frequency of
diabetes-related complications.[23] However, the evidence with
respect to diabetic retinopathy is conflicting with some studies
showing no association with socioeconomic position [24,25] or
giving inconsistent results [26]. While our analyses were adjusted
for deprivation score, residual confounding might have been
present as deprivation was measured at small-area level rather
than being based on individual subject characteristics. The
specificity of the association for achievement of the HbA1c target
and the lack of association with the blood pressure or cholesterol
target argue against this interpretation. Socio-economic position
was more strongly associated with poor performance than with
high performance, but retinopathy was less strongly associated
with poor performance and more strongly associated with high
performance. However, elevated HbA1c may be part of the causal
pathway linking lower socio-economic position to retinopathy.
Socioeconomic position is not a true confounder. Even if targets
are more readily achieved by practices serving more affluent
populations, this does not vitiate the conclusion that the resulting
better control of blood glucose may contribute to lower risk of
retinopathy.
An additional explanation for the association of target
achievement with diabetes eye screening outcomes is the socio-
economic patterning of screening uptake. In particular, screening
uptake was lower at low-performing practices and screening
uptake may be differential with respect to the risk of retinopathy.
However, a previous study found only modest socio-economic
inequalities in diabetes eye screening outcomes in the study
area.[25,27]
Ascertainment of early diabetes might be greater at better
performing practices, leading to a higher prevalence of diabetes
and apparently lower frequency of retinopathy. Our analyses were
adjusted for diabetes prevalence. However, at the level of the
family practice, distributions of age or ethnicity may have an
important influence on diabetes prevalence and our estimates for
diabetes prevalence were not adjusted for these variables.
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Individual-level data for diabetic retinopathy grade were
clustered by family practice as evidenced by the positive intraclass
correlation coefficients for retinal disease. This was recognised in
analyses in which random effects logistic models were used to
inflate standard errors for clustering. Additional analyses were
implemented using either Generalised Estimating Equations.
Either of these analytical approaches gave results that were
generally consistent with those presented. However, the small
magnitude of the ICCs suggests that even at higher- or lower-
performing practices, individual level characteristics such as the
duration of diabetes or the quality of blood glucose control in each
subject are, as expected, crucial in determining the distribution of
diabetic retinal disease.
Data for HbA1c were aggregated to practice level and only
referred to the achievement of a single target of #7.5%. Estimated
associations were somewhat sensitive to whether quartiles or
tertiles were used. We used an approach to modelling the time
dimension that required practices to have remained in the highest
or lowest quartile of performance over four years. A more
sophisticated approach to analysis might be to model the
achievement of the HbA1c target as a continuous variable in
repeated measures framework. However, as there are as yet only
four time points represented in the dataset, accumulation of
further years’ data would provide suitable material for such an
analysis.
The present data provide evidence that family practices that on
aggregate achieve highly on the HbA1c quality of care target over
a period of at least four years, may have lower risk of retinopathy
among their registered diabetic patients. This supports the notion
that initiatives to promote quality of care, with targets for
intermediate measures, may be associated with improved long-
term health outcomes. Practices that remained in the highest
quartile for fewer than four years did not show an association with
retinopathy. This draws attention to the potential importance of
longer term time horizons than the annual review cycle currently
incentivised in the pay-for-performance program. Consistent
achievement of targets over longer periods than one year may
merit particular attention. We acknowledge a number of
limitations to the interpretation of the present data, nevertheless
our study demonstrates the potential of data linkage in the future
evaluation of policy interventions. Future analyses should aim to
provide additional information by utilising data collected over
longer periods of time, and by evaluating incident eye disease both
before and after the introduction of quality of care initiatives.
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